OQROGet OQRO Pro
Fund moves

Kiniksa Pharmaceuticals International (KNSA)Rubric Capital Management LP added to its stake +421K shares

Rubric Capital Management LP added to its stake in Kiniksa Pharmaceuticals International, per its Q1 2026 13F.

3.75M
Shares reported · +421K vs prior quarter
1.9%
Disclosed portfolio weight
$181M
Reported value
Holdings as of
Mar 31, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Apr 28, 2026Company filing · Form 8-K · ResultsReported its results
  2. Apr 30, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 30, 2026, Eben Tessari informed Kiniksa Pharmaceuticals International, plc (the “Company”) of his decision to resign as Chief Strategy Officer of the Company to pursue another executive position within the life sciences industry.”

What came next

  1. May 21, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
  2. Jul 28, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Kiniksa Pharmaceuticals International

For Kiniksa Pharmaceuticals International, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its KNSA page.

How this filing works

Other disclosures at Kiniksa Pharmaceuticals International

Everything OQRO holds on this company is on its KNSA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data